Rhythm Pharmaceuticals (RYTM) Research & Development (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Research & Development of $43.43 million for Q2 2026, up 2.6% from $42.31 million a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Research & Development (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rhythm Pharmaceuticals' Research & Development came in at $173.21 million, up 9.4% year-over-year; for FY2025, it came in at $167.34 million, down 29.7% from FY2024.
- Research & Development has a five-year compound annual growth rate of 13.1% (FY2020 to FY2025).
- By year, Research & Development came in at $237.96 million in FY2024 (+76.3%), $134.95 million in FY2023 (+24.2%), $108.63 million in FY2022 (+4.3%) and $104.13 million in FY2021 (+15.1%).
- Five-year quarterly Research & Development spans a low of $21.12 million in Q3 2022 and a high of $128.67 million in Q1 2024.
- Year over year, Research & Development has now increased in each of the last five quarters, with growth averaging 7.3% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q1 2024 (growth of 239.1%); the low point was Q1 2025 (a decline of 71.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $41.73 million (Q1 2026), $42.03 million (Q4 2025) and $46.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Rhythm Pharmaceuticals | 6.78 Bn | 5.65 Bn | 62.32 Mn | 43.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.43 Mn |
| Mar 31, 2026 | 41.73 Mn |
| Dec 31, 2025 | 42.03 Mn |
| Sep 30, 2025 | 46.03 Mn |
| Jun 30, 2025 | 42.31 Mn |
| Mar 31, 2025 | 36.97 Mn |
| Dec 31, 2024 | 41.17 Mn |
| Sep 30, 2024 | 37.93 Mn |
| Jun 30, 2024 | 30.19 Mn |
| Mar 31, 2024 | 128.67 Mn |
| Dec 31, 2023 | 29.89 Mn |
| Sep 30, 2023 | 33.57 Mn |
| Jun 30, 2023 | 33.54 Mn |
| Mar 31, 2023 | 37.95 Mn |
| Dec 31, 2022 | 23.55 Mn |
| Sep 30, 2022 | 21.12 Mn |
| Jun 30, 2022 | 31.46 Mn |
| Mar 31, 2022 | 32.51 Mn |
| Dec 31, 2021 | 31.57 Mn |
| Sep 30, 2021 | 27.54 Mn |
API Access
Rhythm Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();